Cell And Gene Articles, App Notes, Case Studies, & White Papers

1. Optimizing AAV Purification for High Recovery 2/27/2024

   How can you improve purification methods for your AAVs and enhance the efficacy and safety of your gene therapy treatments?

2. ABSL-3 Facility For Duke (National University of Singapore) 6/6/2024

   Read about a 5-module ABSL-3 facility that was constructed in Singapore, and is used for disease surveillance, research on avian influenza, and other risk group 3 materials.

3. Analyzing Critical Quality Attributes Of Monoclonal Antibodies 5/22/2024

   Use microchip CE-MS technology to achieve quicker peptide mapping analysis, high sample reproducibility, and low artificially induced modifications.

4. The Advantages Of A Blended Learning Approach In Operator Training 5/30/2024

   Explore blended learning and its advantages over traditional operator training methods, which often reduce training to a repetitive but necessary checklist of reading and acknowledging procedures.

5. Phototrophic Cultivation Of Chlorella vulgaris In Microbioreactors 12/18/2025

   Unlock efficient microalgae cultivation with precise lighting and real-time insights. Explore ways to boost biomass, optimize growth, and accelerate sustainable bioenergy and bioproduct innovation.

6. Study: Ensuring Homogeneity In Biopharmaceutical Aliquotation 1/17/2025

   Tired of manual manipulation risks in biopharmaceuticals? Discover how automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.

7. Oligonucleotides: Where We Are And Where We Would Like To Go  9/8/2024

   This presentation provides an overview of oligonucleotide bioanalysis's current status and future directions. We will look into the advantages and disadvantages of various bioanalytical techniques.

8. Expansion Of Human Bone Marrow-Derived MSCs 11/3/2025

   Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.

9. AAV-Based Gene Editing For Huntington's Disease 10/28/2025

   LETI-101 uses AAV5 to deliver a compact CRISPR system for allele-selective editing of mutant HTT, showing promise as a one-time treatment for Huntington’s disease with strong preclinical safety and efficacy.

10. Don't Let Distribution Derail Your CGT Launch 8/7/2025

    Overcoming distribution challenges is critical for the success of cell and gene therapies. Learn how to build a flexible, robust strategy to optimize patient access.